Krispy Kreme Faces 16 Million Data Breach Settlement Deadline Who Is Eligible to File Nifty 50s LongTerm Track Record Sends Reassuring Signal to FPIs Dont Write Me Off Just Yet Prediction Market Odds Rise for Fed Rate Hike by July 2027 Bessent Forecasts Substantial Disinflation as Warsh Poised to Lead Federal Reserve Bitcoin and Ethereum Extend Losses as 400 Million in Crypto Liquidations Hit Market Amid Macro and Geopolitical Concerns Roundhill Memory ETF Surges 85 Since Debut Becoming FastestGrowing Fund on Record SIRI Q1 2026 Earnings EPS Beats Estimates Yet Stock Slips Acadian Asset Management Inc Q1 2026 Earnings Strong EPS Beat Despite Modest Stock Decline Marriott Vacations Worldwide VAC Q1 2026 Earnings EPS Miss Weighs on Sentiment but Stock Ticks Higher Mosaic Company MOS Q1 2026 Earnings EPS Falls Short by 79 Stock Rises Unexpectedly NuCana Q3 2024 Earnings SmallerthanExpected Loss as Biotech Advances Oncology Pipeline Presidio Property Trust Q3 2023 Earnings Net Loss Widens as Real Estate Headwinds Persist ClearThink 1 Acquisition Corp Units CTAAU Hold Steady at 1006 Amid Minimal Price Movement Seritage Growth Properties SRG Surges 894 Support and Resistance Levels in Focus Iron Mountain IRM Holds Steady Near Support as Data Center Demand Bolsters Outlook GMEX Robotics Slides 262 as Shares Test Key Support at 177 BioLife Solutions BLFS Dips 138 Support Test Looms Market Not in a Bubble Analyst Suggests Wall Street Hasnt Adapted to New Market Dynamics UNP Q1 2026 Earnings EPS Beats Estimates Amid Strong Operational Performance Social Commerce Partners Warrant SCPQW Surges 133 as Investors Eye Key Resistance Level Telomir Pharmaceuticals TELO Trades Near Support at 121 After Slight Decline Reeds Inc REED Drops 695 as Shares Test Key Support at 165 Upland Software UPLD Jumps 167 to 082 Approaching Key Resistance at 086 Jumia Technologies JMIA Rallies 244 as ECommerce Stock Tests Resistance Near 750 Fiserv FISV Holds Steady Near Midpoint of Range as Investors Assess Support and Resistance HEPS Holds Steady at 276 Support and Resistance Levels in Focus AN2 Therapeutics Stock Slips Modestly Amid Consolidation Near Support Levels ANTX